Intranasal dexmedetomidine and rectal ketamine for young children undergoing burn wound procedures

Andrea Frestadius1, Filip Grehn2, Morten Kildal3

  • 1Burn Center, Department of Plastic and Maxillofacial Surgery, Uppsala University Hospital, 751 85 Uppsala, Sweden.

Insights

Intranasal dexmedetomidine and rectal ketamine offer safe procedural sedation for pediatric burn patients. This combination effectively manages pain and provides stable sedation, though some cases may require additional anesthesia.

Area of Science:

  • Pediatric Anesthesiology
  • Burn Management
  • Pharmacology

Background:

  • Effective sedation and analgesia are critical for pediatric burn patients undergoing painful procedures.
  • Current methods require evaluation for safety and efficacy in this vulnerable population.

Purpose of the Study:

  • To assess the safety and efficacy of intranasal dexmedetomidine combined with rectal ketamine for procedural sedation in young children with burn wounds.
  • To evaluate complications, adverse effects, pain levels, sedation depth, and recovery times.

Main Methods:

  • Retrospective analysis of electronic health records from 90 procedures in 58 pediatric patients (<5 years old).
  • Assessment of safety and efficacy based on documented outcomes including adverse events and pain scores.

Main Results:

  • No significant adverse events requiring acute airway management or medical intervention occurred in 90 sedations.
  • The dexmedetomidine-ketamine combination provided effective analgesia during procedures and for postoperative pain, with 7.8% of patients requiring conversion to intravenous anesthesia.
  • Two cases experienced delayed awakening (>120 min recovery time), and 23% required additional doses of either agent.

Conclusions:

  • Intranasal dexmedetomidine and rectal ketamine represent a safe and reliable sedation and analgesia strategy for pediatric burn wound procedures.
  • This combination ensures a clinically stable sedative condition that necessitates only basic monitoring.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
324
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
685
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
570
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
403